摘要
目的 研究左西孟旦与米力农治疗心力衰竭的治疗效果。方法 选择2014年10月-2015年4月来我院治疗心力衰竭的患者70例,随机分成两组,每组35例,对照组患者采用米力龙,治疗组患者采用左西孟旦,观察两组患者治死亡率及各项指标。结果 两组患者都未发生死亡,对照组患者的治疗总有效率为68.57%低于治疗组88.57%的治疗总有效率,差异有统计学意义（P〈0.05）;治疗后治疗组患者的各项指标高于对照组患者,差异有统计学意义（P〈0.05）。结论 对心力衰竭患者采用左西孟旦比米力龙治疗效果更佳。
Objective To study the therapeutic effect of levosimendan and milrinone in the treatment of heart failure. Methods 70 cases of patients with heart failure were randomly divided into two groups during October 2014 to April 2015 since our hospital,35 cases each. In the control group were treated with milrinone dragon,the treatment group were treated with levosimendan. Governance indicators observed mortality and patient groups. Results Two patients died had happened,the treatment of patients in the control group total effective rate was 68.57% in treatment group was significantly lower than the 88.57% of the total efficiency of the treatment,the difference was statistically significant（P〈0.05）,the index after treatment was significantly higher in patients treated with the patient,the difference there was statistically significant（P〈0.05）. Conclusion The use of levosimendan in heart failure patients than milrinone Long treatment better,can be extended.
出处
《中国卫生标准管理》
2015年第22期107-108,共2页
China Health Standard Management
